Jyong Biotech Ltd. (MENS)Healthcare | Biotechnology | New Taipei City, Taiwan | NasdaqGM
2.21 USD
|
Hot Take ↕ | July 11, 2026, 5:49 a.m. EDT
The investment case here is fundamentally broken. The company is bleeding cash with negative operating cash flow and a massive debt load of nearly $18.5 million against a mere $1.2 million in cash reserves. The balance sheet is precarious, evidenced by a current ratio of just 0.45 and negative book value. While the stock recently staged a technical bounce off its lows, the underlying business quality is deteriorating, highlighted by the CEO's significant wealth destruction as his holdings plummeted 33%. There is no dividend to provide income, and the options market shows almost no speculative interest, indicating a lack of confidence in any near-term catalyst. This is a high-risk speculative vehicle with no margin of safety. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.135877 |
| MSTL_53 | 0.255675 |
| AutoARIMA | 0.264507 |
| AutoETS | 0.264512 |
| MSTL | 0.265959 |
Forecast horizon: 60 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 28% |
| H-stat | 1.90 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.639 |
| Excess Kurtosis | -0.24 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 168,021,136 |
| Website | https://jyongbio.com |
As of July 11, 2026, 5:49 a.m. EDT: Speculator positioning is extremely thin and fragmented. Call volume is negligible across all expirations, with only minor activity at the $2.50 strike. Put activity is similarly sparse, concentrated entirely at the $2.50 strike with minimal open interest. The lack of meaningful volume or open interest suggests a vacuum of speculative conviction rather than a clear directional bet.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8111111 |
| Address1 | No. 95, Xintai 5th Road |
| Address2 | 23F-3 Section 1 Xizhi District |
| All Time High | 67.0 |
| All Time Low | 1.43 |
| Ask | 2.76 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 95,220 |
| Average Daily Volume3 Month | 100,190 |
| Average Volume | 100,190 |
| Average Volume10Days | 95,220 |
| Bid | 1.59 |
| Bid Size | 2 |
| Book Value | -0.336 |
| City | New Taipei City |
| Country | Taiwan |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 2.21 |
| Current Ratio | 0.446 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 2.27 |
| Day Low | 2.15 |
| Display Name | Jyong Biotech |
| Ebitda | -2,507,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -72.369 |
| Enterprise Value | 181,429,840 |
| Eps Trailing Twelve Months | -0.06 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.0139 |
| Fifty Day Average Change | 0.1961 |
| Fifty Day Average Change Percent | 0.097373255 |
| Fifty Two Week Change Percent | -81.11111 |
| Fifty Two Week High | 67.0 |
| Fifty Two Week High Change | -64.79 |
| Fifty Two Week High Change Percent | -0.96701497 |
| Fifty Two Week Low | 1.43 |
| Fifty Two Week Low Change | 0.7800001 |
| Fifty Two Week Low Change Percent | 0.5454546 |
| Fifty Two Week Range | 1.43 - 67.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,750,167,000,000 |
| Float Shares | 26,941,531 |
| Free Cashflow | 4,385,750 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 27 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.622 |
| Held Percent Institutions | 0.00712 |
| Implied Shares Outstanding | 76,027,668 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,025-06-17 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Jyong Biotech Ltd., a science-driven biotechnology company, engages in the development and commercialization of plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops Botreso, for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan. |
| Long Name | Jyong Biotech Ltd. |
| Market | us_market |
| Market Cap | 168,021,136 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1853012762 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -4,671,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 162,571,730 |
| Open | 2.2 |
| Operating Cashflow | -3,041,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 886 2 2732 5205 |
| Previous Close | 2.21 |
| Price Hint | 4 |
| Price To Book | -6.577381 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.034 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0 |
| Regular Market Change Percent | 0.0 |
| Regular Market Day High | 2.27 |
| Regular Market Day Low | 2.15 |
| Regular Market Day Range | 2.15 - 2.27 |
| Regular Market Open | 2.2 |
| Regular Market Previous Close | 2.21 |
| Regular Market Price | 2.21 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 90,286 |
| Return On Assets | -0.12005 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 74,233,667 |
| Shares Percent Shares Out | 0.0028 |
| Shares Short | 208,547 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 249,727 |
| Short Name | Jyong Biotech Ltd. |
| Short Percent Of Float | 0.0050999997 |
| Short Ratio | 1.32 |
| Source Interval | 15 |
| Symbol | MENS |
| Total Cash | 1,175,000 |
| Total Cash Per Share | 0.016 |
| Total Debt | 18,549,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.06 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 14.117 |
| Two Hundred Day Average Change | -11.907 |
| Two Hundred Day Average Change Percent | -0.84345114 |
| Type Disp | Equity |
| Volume | 90,286 |
| Website | https://jyongbio.com |
| Zip | 221 |